Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta-analysis

被引：0
|
作者：
Somay, Efsun [1 ]
机构：
[1] Baskent Univ, Fac Dent, Dept Oral & Maxillofacial Surg, 82 St 26 Bahcelievler, Ankara, Turkiye
来源：
SPECIAL CARE IN DENTISTRY | 2024年 / 44卷 / 02期
关键词：
D O I：
10.1111/scd.12909
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：615 / 616
页数：2
相关论文
共 50 条
  • [1] Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta-analysis
    Zhang, Chengrong
    Shen, Guoshuang
    Li, Huihui
    Xin, Yuanfang
    Shi, Mingqiang
    Zheng, Yonghui
    Wang, Miaozhou
    Liu, Zhen
    Zhao, Yi
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Jiuda
    SPECIAL CARE IN DENTISTRY, 2024, 44 (02) : 530 - 541
  • [2] Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab
    Loyson, Tine
    Van Cann, Thomas
    Schoffski, Patrick
    Clement, Paul M.
    Bechter, Oliver
    Spriet, Isabel
    Coropciuc, Ruxandra
    Politis, Constantinus
    Vandeweyer, Raf O.
    Schoenaers, Joseph
    Dumez, Herlinde
    Berteloot, Patrick
    Neven, Patrick
    Nackaerts, Kristiaan
    Woei-A-Jin, Feng J. S. H.
    Punie, Kevin
    Wildiers, Hans
    Beuselinck, Benoit
    ACTA CLINICA BELGICA, 2018, 73 (02) : 100 - 109
  • [3] BISPHOSPHONATES AND RISK OF OSTEONECROSIS OF JAW IN CANCER PATIENTS: A META-ANALYSIS
    Leung, H. W.
    Chan, A. L.
    Ko, J.
    VALUE IN HEALTH, 2012, 15 (07) : A653 - A653
  • [4] BISPHOSPHONATES-ASSOCIATED OSTEONECROSIS OF JAW IN CANCER PATIENTS: A META-ANALYSIS
    Lin, H. C.
    Lin, S. J.
    Chan, A. L.
    VALUE IN HEALTH, 2013, 16 (07) : A392 - A392
  • [5] Incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases treated with bisphosphonates and/or denosumab: some comments and questions
    Fusco, Vittorio
    Rossi, Maura
    De Martino, Iolanda
    Alessio, Manuela
    Fasciolo, Antonella
    Numico, Gianmauro
    ACTA CLINICA BELGICA, 2018, 73 (02) : 163 - 164
  • [6] Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors
    Bamias, A
    Kastritis, E
    Bamia, C
    Moulopoulos, LA
    Melakopoulos, L
    Bozas, G
    Koutsoukou, V
    Gika, D
    Anagnostopoulos, A
    Papadimitriou, C
    Terpos, E
    Dimopoulos, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8580 - 8587
  • [7] Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
    Kos, Marcin
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (02) : 319 - 324
  • [8] Use of Bisphosphonates and the Risk of Osteonecrosis: A Systematic Review and Meta-Analysis of Observational Studies
    Lee, Chien-Chang
    Chen, Yun-Ning
    Chen, Hung-Wen
    Lee, Si-Huei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 414 - 414
  • [9] Incidence Rate of Potential Osteonecrosis of the Jaw Among Women with Postmenopausal Osteoporosis Treated with Prolia or Bisphosphonates
    Xue, Fei
    Wagman, Rachel B.
    Yue, Susan
    Smith, Shawna
    Arora, Tarun
    Curtis, Jeffrey R.
    Ehrenstein, Vera
    Sorensen, Henrik T.
    Tell, Grethe
    Kieler, Helle
    Wang, Florence T.
    Dore, David D.
    Sprafka, J. Michael
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [10] Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis
    Guo, Z.
    Cui, W.
    Que, L.
    Li, C.
    Tang, X.
    Liu, J.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2020, 49 (03) : 298 - 309
12345